Furthermore, IL-17 recruits myeloid-derived suppressor cells (MDSCs) into the tumor microenvironment, fostering an immunosuppressive milieu that attenuates anti-tumor immune responses (89). The gene discussed is IL17A; the disease is neoplasm.